Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antibody microarray-based oncoproteomics.

Carl A K Borrebaeck1

  • 1Lund University, Department of Immunotechnology, BMC D13, SE-221 84 Lund, Sweden. carl.borrebaeck@immun.lth.se

Expert Opinion on Biological Therapy
|July 22, 2006
PubMed
Summary

Oncoproteomics aims to identify cancer-specific protein signatures for predicting disease progression and improving therapies. Antibody microarrays offer a promising proteome-wide approach to overcome current technological challenges in cancer research.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cost savings and quality-of-life gains associated with the use of an AI-powered digital tool for self-management of chronic pain based on a multicenter cohort study.

Pain medicine (Malden, Mass.)·2026
Same author

Multilayered Epigenetic Analysis Identifies a Molecular Portrait for Psychological Resilience in Patients With Breast Cancer.

Biological psychiatry global open science·2025
Same author

Distinct Infiltration of T Cell Populations in Bladder Cancer Molecular Subtypes.

Cells·2024
Same author

An artificial intelligence-powered, patient-centric digital tool for self-management of chronic pain: a prospective, multicenter clinical trial.

Pain medicine (Malden, Mass.)·2023
Same author

One-year recovery from breast cancer: Importance of tumor and treatment-related factors, resilience, and sociodemographic factors for health-related quality of life.

Frontiers in oncology·2022
Same author

Transcriptional profiling demonstrates altered characteristics of CD8<sup>+</sup> cytotoxic T-cells and regulatory T-cells in TP53-mutated acute myeloid leukemia.

Cancer medicine·2022

Area of Science:

  • Biochemistry
  • Oncology
  • Proteomics

Background:

  • Oncoproteomics seeks protein signatures linked to specific malignancies for clinical parameter correlation.
  • Predicting disease progression and therapeutic strategies relies on understanding protein expression patterns.
  • Significant technological hurdles exist due to the undefined human proteome and cancer heterogeneity.

Purpose of the Study:

  • To review the role of antibody microarrays in oncoproteomics.
  • To explore the potential of antibody microarrays for proteome-wide cancer analysis.
  • To highlight antibody microarrays as a solution for identifying cancer-associated protein signatures.

Main Methods:

  • Focuses on affinity proteomics, a technology combining proteomics with microarrays.
  • Utilizes antibody microarrays for high-throughput protein analysis.
  • Addresses limitations of traditional proteomics methods.

Main Results:

  • Antibody microarrays show potential for comprehensive proteome-wide analysis in cancer.
  • This approach can aid in identifying specific protein signatures associated with malignancies.
  • Overcomes some limitations of conventional proteomics.

Conclusions:

  • Antibody microarrays are a key emerging technology in oncoproteomics.
  • This approach holds significant promise for advancing cancer diagnostics and therapeutics.
  • Enables a more complete proteome-wide analytical strategy for cancer research.

Related Experiment Videos